This course has expired. You can still review the content but course credit is no longer available.
Join Drs. Jennifer I. Lim and Yoshihiro Yonekawa as they discuss challenging cases of neovascular age-related macular degeneration, current treatments, and how investigative therapies may change the way patients with these conditions are managed in the future. A live question-and-answer session will follow the presentation.
This certified CME activity is designed for retina specialists who treat patients with retinal diseases.
Supported by an educational grant from Genentech, a member of the Roche Group.
At the completion of this educational activity, you will be better able to:
This educational activity is provided by Evolve Medical Education LLC (Evolve).
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Recommended internet speed 5Mbps+
Jennifer I. Lim, MD
Marion H. Schenk Chair in Ophthalmology
Professor of Ophthalmology
Vice-Chair for Diversity & Inclusion
Director of the Retina Service
University of Illinois at Chicago
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Jennifer I. Lim, MD and or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Cognition, Genentech, Novartis, and Regeneron Pharmaceuticals. Data Monitoring Committee: Aura Bioscience, Ophthea, Quark, and Santen. Grant/Research Support: Allergan, Chengdu Pharma, Genentech, Graybug, Regeneron Pharmaceuticals, and Stealth. Speaker’s List: Iveric Bio.
Yoshihiro Yonekawa, MD, and or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Alimera, and Genentech.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Genentech, a member of the Roche Group.